Articles by Disease (Hypotension )

Prostaglandin E2 Receptors as Potential Bone Anabolic Targets – Selective EP4 Receptor Agonists

Journal: Current Molecular Pharmacology
Volume: 5
Page: 174-181
Author(s): Joseph Pagkalos, Andreas Leonidou, Mohammed As-Sultany, Manolis Heliotis, Athanasios Mantalaris and Eleftherios Tsiridis

Effects of PPARγ Ligands on Vascular Tone

Journal: Current Molecular Pharmacology
Volume: 5
Page: 282-291
Author(s): Salvatore Salomone and Filippo Drago

Anti-Vascular Endothelial Growth Factor Treatment in Retinal Vein Occlusions

Journal: Current Drug Therapy
Volume: 7
Page: 101-116
Author(s): David J. Browning

“The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives

Journal: Current Drug Therapy
Volume: 7
Page: 144-149
Author(s): Niraj S. Vyawahare, Varsha J. Bansode and Neeraj B. Munjal

Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs

Journal: Current Drug Therapy
Volume: 7
Page: 80-89
Author(s): Michael W. Stewart

Arachidonate Cascade in the Intensive Insulin Therapy for Critically Ill Patients with Sepsis: Roles of Prostaglandins on Hyperglycemia-Impaired Immunity

Journal: Letters in Drug Design & Discovery
Volume: 9
Page: 557-567
Author(s): Tatsurou Yagami, Yasuhiro Yamamoto, Hiromi Kohma and Kenkichi Takase

Introduction to the Special Issue “Pharmacotherapies for the Treatment of Alcohol Abuse and Dependence” and a Summary of Patents Targeting other Neurotransmitter Systems

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 7
Page: 93-112
Author(s): Richard L. Bell, Kelle M. Franklin, Sheketha R. Hauser and Feng C. Zhou